Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 15,161 shares at $527.47 ($8.0M) on 2026-03-19, disclosed to the SEC on 2026-03-19.
Scheduled sale ($8.0M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $527.47 | 753 | $397K | 4.9% |
| 2 | $527.47 | 753 | $397K | 4.9% |
| 3 | $528.41 | 1,439 | $760K | 9.5% |
| 4 | $529.82 | 2,808 | $1.5M | 18.5% |
| 5 | $529.82 | 2,808 | $1.5M | 18.5% |
| 6 | $530.63 | 1,776 |
| $942K |
| 11.7% |
| 7 | $530.63 | 1,776 | $942K | 11.7% |
| 8 | $531.62 | 794 | $422K | 5.3% |
| 9 | $531.62 | 794 | $422K | 5.3% |
| 10 | $532.50 | 650 | $346K | 4.3% |
| 11 | $532.50 | 650 | $346K | 4.3% |
| 12 | $533.41 | 80 | $43K | 0.5% |
| 13 | $533.41 | 80 | $43K | 0.5% |
| Total | $530.10 avg | 15,161 | $8.0M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |